Atria Investments
KRYS icon

Atria Investments’s Krystal Biotech KRYS Stock Holding History

Atria Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$215K Buy
+646
New +$224K ﹤0.01% 2048

Other funds holding KRYS

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $251M AUM 42.58% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return
TNAM
Terra Nova Asset Management New York $155M AUM 33.52% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return

Atria Investments's KRYS Position: Q3 2026 in Review

Atria Investments opened a new position in Krystal Biotech (KRYS) in Q3 2026: 646 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #2048 among its holdings.

26 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Atria Investments held 646 shares of Krystal Biotech worth $215K as of Q3 2026.
  • Krystal Biotech was a new Atria Investments position in Q3 2026.
  • Krystal Biotech made up ﹤0.01% of Atria Investments's portfolio in Q3 2026, its #2048 holding.
  • 26 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Atria Investments's 13F filing for Q3 2026, filed 15 Oct 2026.